Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of subcutaneous low molecular weight heparin injection technique on bruising and pain
TCTR20160426004Phase 3Completed
- Sponsor
- Siriraj Research Development Fund
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by Siriraj Research Development Fund. Started Aug 2014; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20160426004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160426004.